These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24680485)

  • 1. Endothelial progenitor cells and pulmonary arterial hypertension.
    Chen H; Strappe P; Chen S; Wang LX
    Heart Lung Circ; 2014 Jul; 23(7):595-601. PubMed ID: 24680485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial progenitor cells in pulmonary arterial hypertension.
    Diller GP; Thum T; Wilkins MR; Wharton J
    Trends Cardiovasc Med; 2010 Jan; 20(1):22-9. PubMed ID: 20685574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial progenitor cell-based therapy for pulmonary arterial hypertension.
    Yang JX; Pan YY; Zhao YY; Wang XX
    Cell Transplant; 2013; 22(8):1325-36. PubMed ID: 23295102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hypoxia inducible factor-1α and homogeneous endothelial progenitor cell therapy attenuates shunt flow-induced pulmonary arterial hypertension in rabbits.
    Cao G; Liu C; Wan Z; Liu K; Sun H; Sun X; Tang M; Bing W; Wu S; Pang X; Zhang X
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):621-32. PubMed ID: 26071969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of eNOS-transfected endothelial progenitor cells on hemodynamic pulmonary arterial hypertension.
    Wei L; Zhu W; Xia L; Yang Y; Liu H; Shen J; Zhu J; Xu Y; Yang Z; Wang C
    Hypertens Res; 2013 May; 36(5):414-21. PubMed ID: 23446773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension.
    Schiavon M; Fadini GP; Lunardi F; Agostini C; Boscaro E; Calabrese F; Marulli G; Rea F
    J Heart Lung Transplant; 2012 Sep; 31(9):1025-30. PubMed ID: 22884387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension.
    Marsboom G; Pokreisz P; Gheysens O; Vermeersch P; Gillijns H; Pellens M; Liu X; Collen D; Janssens S
    Stem Cells; 2008 Apr; 26(4):1017-26. PubMed ID: 18258720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
    Xia L; Fu GS; Yang JX; Zhang FR; Wang XX
    Cytotherapy; 2009; 11(4):492-502. PubMed ID: 19526390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases.
    Suen CM; Mei SH; Kugathasan L; Stewart DJ
    Compr Physiol; 2013 Oct; 3(4):1749-79. PubMed ID: 24265244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of circulating endothelial cells in pulmonary hypertension.
    Smadja DM; Mauge L; Sanchez O; Silvestre JS; Guerin C; Godier A; Henno P; Gaussem P; Israël-Biet D
    Eur Respir J; 2010 Dec; 36(6):1284-93. PubMed ID: 20413531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resident PW1+ Progenitor Cells Participate in Vascular Remodeling During Pulmonary Arterial Hypertension.
    Dierick F; Héry T; Hoareau-Coudert B; Mougenot N; Monceau V; Claude C; Crisan M; Besson V; Dorfmüller P; Marodon G; Fadel E; Humbert M; Yaniz-Galende E; Hulot JS; Marazzi G; Sassoon D; Soubrier F; Nadaud S
    Circ Res; 2016 Mar; 118(5):822-33. PubMed ID: 26838788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative and functional changes of circulating endothelial progenitor cells in dogs with dehydromonocrotaline-induced pulmonary artery hypertension].
    Zeng CL; Xia L; Ma CY; Liu SK; Hu XS; Wang XX; Chen JZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):330-4. PubMed ID: 18953955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
    Humbert M; Montani D; Perros F; Dorfmüller P; Adnot S; Eddahibi S
    Vascul Pharmacol; 2008; 49(4-6):113-8. PubMed ID: 18606248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.
    Jurasz P; Courtman D; Babaie S; Stewart DJ
    Pharmacol Ther; 2010 Apr; 126(1):1-8. PubMed ID: 20117135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension.
    Zhao Q; Liu Z; Wang Z; Yang C; Liu J; Lu J
    Ann Thorac Surg; 2007 Aug; 84(2):544-52. PubMed ID: 17643632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension.
    Ormiston ML; Deng Y; Stewart DJ; Courtman DW
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):546-54. PubMed ID: 19995942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial.
    Granton J; Langleben D; Kutryk MB; Camack N; Galipeau J; Courtman DW; Stewart DJ
    Circ Res; 2015 Sep; 117(7):645-54. PubMed ID: 26195220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescent endothelial progenitor cells from dogs with pulmonary arterial hypertension: a before-after self-controlled study.
    Xia L; Zhu JH; Qiu FY; Yang Y; Xie XD; Wang XX; Chen JZ; Fu GS
    J Physiol Sci; 2009 Nov; 59(6):429-37. PubMed ID: 19636669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells.
    Nagaya N; Kangawa K; Kanda M; Uematsu M; Horio T; Fukuyama N; Hino J; Harada-Shiba M; Okumura H; Tabata Y; Mochizuki N; Chiba Y; Nishioka K; Miyatake K; Asahara T; Hara H; Mori H
    Circulation; 2003 Aug; 108(7):889-95. PubMed ID: 12835224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.